Industries > Pharma > Vaccine Contract Manufacturing Market Report 2016-2026

Vaccine Contract Manufacturing Market Report 2016-2026

Leading Countries, Technologies and Companies

PUBLISHED: 17 December 2015
PAGES: 148
PRODUCT CODE: PHA0083
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0083 Categories: ,

What can be expected from the vaccine contract manufacturing market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
 
Our 148-page report provides 76 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analysis and commercial developments.

See revenue forecasts for the leading international markets
How will leading national markets perform to 2026? Our study forecasts revenues in national markets including products, including:
• US
• Germany
• France
• Italy
• Spain
• UK
• Japan
• China
• Brazil
• Russia
• India

Vaccine Contract Manufacturing Market Report 2016-2026

Leading companies and potential for market growth
Overall revenue for the vaccine contract manufacturing market will reach $1047.3m in 2019, our work forecasts. We predict good revenue growth through to 2026. Increasing demands for therapeutic vaccines and an ageing population will help drive the market for vaccines over the forecast period, which in turn helps drive the vaccine contract manufacturing business.

Our work analyses the key companies in the market. See Visiongain’s analysis of leading companies, including these:
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridian Life Science
• Sigma Aldrich Fine Chemical (Merck)
• Synco Bio Partners

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Company news relevant to the market

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies

What issues will affect Vaccine contract manufacturing industry?
Our new report discusses issues and events affecting the vaccine contract manufacturing market. You will find discussions, including qualitative analyses:
• The emergence of developing markets as manufacturing centres
• Increasing potential in both established and emerging markets

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Vaccine Contract Manufacturing Market 2016-2026 report helps you
In summary, our 148-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the vaccine contract manufacturing market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets – US, Japan, EU5 (Germany, UK, France, Italy and Spain), China, India, Brazil and Russia
• Assessment of leading companies – analysis of vaccine manufacturing capabilities, revenue and news (Baxter BioPharma Solutions, Boehringer Ingelheim, Catalent, Charles River Laboratories, IDT Biologika, Lonza, Meridian Life Science, Sigma Aldrich Fine Chemical (Merck), Synco Bio Partners)
• Discussion of what stimulates and restrains companies and the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the vaccine contract manufacturing market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Report 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Report 2016-2026


Latest Pharma news

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Visiongain Publishes Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031

Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.

31 March 2021

READ

Categories